{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T15:49:33Z","timestamp":1778428173459,"version":"3.51.4"},"reference-count":28,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Sarcopenia is highly prevalent among patients with chronic kidney disease (CKD) and chronic heart failure (CHF), yet the underlying immunometabolic mechanisms remain insufficiently understood. Short-chain fatty acids (SCFAs), inflammatory cytokines, and body-composition alterations may jointly contribute to the development of muscle dysfunction in this population. In this cross-sectional study, 80 patients with CKD and CHF underwent comprehensive clinical, biochemical, bioimpedance, inflammatory, and SCFA profiling. Sarcopenia was diagnosed according to EWGSOP2 criteria. Multivariable logistic regression, LASSO feature selection, correlation analysis, PCA, and Random Forest modeling were used to identify key determinants of sarcopenia. Sarcopenia was present in 39 (49%) participants. Patients with sarcopenia exhibited significantly lower body fat percentage, reduced ASM, and slower gait speed. Hexanoic acid (C6) showed an independent positive association with sarcopenia (OR = 2.24, 95% CI: 1.08\u20135.37), while IL-8 showed an inverse association with sarcopenia (OR = 0.38, 95% CI: 0.13\u20130.94), indicating that lower IL-8 levels were more frequently observed in individuals with sarcopenia. Correlation heatmaps revealed distinct SCFA\u2013cytokine coupling patterns depending on sarcopenia status, with stronger pro-inflammatory clustering in C6-associated networks. The final multivariable model integrating SCFAs, cytokines, and body-composition metrics achieved excellent discrimination (AUC = 0.911) and good calibration. Sarcopenia in CKD\u2013CHF patients represents a systemic immunometabolic disorder characterized by altered body composition, chronic inflammation, and dysregulated SCFA signaling. Hexanoic acid (C6) and IL-8 may serve as informative biomarkers of muscle decline. These findings support the use of multidimensional assessment and highlight potential targets for personalized nutritional, microbiota-modulating, and rehabilitative interventions.<\/jats:p>","DOI":"10.3390\/ijms27010550","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:07:07Z","timestamp":1767629227000},"page":"550","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Plasma Short-Chain Fatty Acids and Cytokine Profiles in Chronic Kidney Disease: A Potential Pathophysiological Link"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0823-9190","authenticated-orcid":false,"given":"Anna V.","family":"Sokolova","sequence":"first","affiliation":[{"name":"Department of Propaedeutics of Internal Diseases No. 1, Institute of Clinical Medicine, Federal State Autonomous Educational Institution of Higher Education \u2018N.I. Pirogov Russian National Research Medical University\u2019 of the Ministry of Health of the Russian Federation, 117513 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1059-8387","authenticated-orcid":false,"given":"Dmitrii O.","family":"Dragunov","sequence":"additional","affiliation":[{"name":"Department of Propaedeutics of Internal Diseases No. 1, Institute of Clinical Medicine, Federal State Autonomous Educational Institution of Higher Education \u2018N.I. Pirogov Russian National Research Medical University\u2019 of the Ministry of Health of the Russian Federation, 117513 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6645-2515","authenticated-orcid":false,"given":"Grigory P.","family":"Arutyunov","sequence":"additional","affiliation":[{"name":"Department of Propaedeutics of Internal Diseases No. 1, Institute of Clinical Medicine, Federal State Autonomous Educational Institution of Higher Education \u2018N.I. Pirogov Russian National Research Medical University\u2019 of the Ministry of Health of the Russian Federation, 117513 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1046\/j.1532-5415.2003.51534.x","article-title":"Sarcopenia: Alternative Definitions and Associations with Lower Extremity Function","volume":"51","author":"Newman","year":"2003","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/ndt\/gft070","article-title":"Uraemic Sarcopenia: Aetiology and Implications","volume":"29","author":"Fahal","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"115407","DOI":"10.1016\/j.bcp.2022.115407","article-title":"Chronic Kidney Disease-Induced Muscle Atrophy: Molecular Mechanisms and Promising Therapies","volume":"208","author":"Wang","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.18565\/nephrology.2019.1.48-55","article-title":"Prognostic Value of Sarcopenia in Patients with CKD","volume":"2019","author":"Sokolova","year":"2019","journal-title":"Nephrology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.18565\/nephrology.2023.3.18-23","article-title":"The Prevalence of Sarcopenia in Patients with Chronic Heart Failure and Chronic Kidney Disease","volume":"2023","author":"Sokolova","year":"2023","journal-title":"Nephrology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12967-024-04974-6","article-title":"Gut Microbial Metabolites SCFAs and Chronic Kidney Disease","volume":"22","author":"He","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1111\/bph.15472","article-title":"Triptolide Prevents LPS-Induced Skeletal Muscle Atrophy via Inhibiting NF-\u03baB\/TNF-\u03b1 and Regulating Protein Synthesis\/Degradation Pathway","volume":"178","author":"Fang","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Margiotta, E., Caldiroli, L., Callegari, M.L., Miragoli, F., Zanoni, F., Armelloni, S., Rizzo, V., Messa, P., and Vettoretti, S. (2021). Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress. Toxins, 13.","DOI":"10.3390\/toxins13070472"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Lu, R., Wang, S., Chen, P., Li, F., Li, P., Chen, Q., Li, X., Li, F., Guo, S., and Zhang, J. (2025). Predictive Model for Sarcopenia in Chronic Kidney Disease: A Nomogram and Machine Learning Approach Using CHARLS Data. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1546988"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Yu, C.-S., Lin, C.-H., Lin, Y.-J., Lin, S.-Y., Wang, S.-T., Wu, J.L., Tsai, M.-H., and Chang, S.-S. (2020). Clustering Heatmap for Visualizing and Exploring Complex and High-Dimensional Data Related to Chronic Kidney Disease. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020403"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Cheng, T.-H., Ma, M.-C., Liao, M.-T., Zheng, C.-M., Lu, K.-C., Liao, C.-H., Hou, Y.-C., Liu, W.-C., and Lu, C.-L. (2020). Indoxyl Sulfate, a Tubular Toxin, Contributes to the Development of Chronic Kidney Disease. Toxins, 12.","DOI":"10.3390\/toxins12110684"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1053\/j.jrn.2013.11.006","article-title":"Indoxyl Sulfate and p-Cresyl Sulfate in Chronic Kidney Disease. Could These Toxins Modulate the Antioxidant Nrf2-Keap1 Pathway?","volume":"24","author":"Fouque","year":"2014","journal-title":"J. Ren. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s40168-025-02220-9","article-title":"Members of Lachnospiraceae Produce Valerate and Caproate in Response to Short-Chain Fatty Acids","volume":"13","author":"Fitzgerald","year":"2025","journal-title":"Microbiome"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408398.2020.1854675","article-title":"The Role of Short-Chain Fatty Acids in Immunity, Inflammation and Metabolism","volume":"62","author":"Yao","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.redox.2018.02.007","article-title":"Differential Effects of Short Chain Fatty Acids on Endothelial Nlrp3 Inflammasome Activation and Neointima Formation: Antioxidant Action of Butyrate","volume":"16","author":"Yuan","year":"2018","journal-title":"Redox Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12964-023-01219-9","article-title":"Short-Chain Fatty Acids in Diseases","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sokolova, A.V., Dragunov, D.O., Klimova, A.V., Golubev, Y.V., Shmigol, T.A., Negrebetsky, V.V., and Arutyunov, G.P. (2025). Prognostic Significance of Plasma Short-Chain Fatty Acid Levels in Assessing Mortality Risk in Patients with Chronic Heart Failure and Sarcopenia. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202505.0252.v1"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.18565\/nephrology.2025.3.36-43","article-title":"Short-Chain Fatty Acids as Predictors of Renal Function Decline in Patients with Sarcopenia and CHF","volume":"17","author":"Sokolova","year":"2025","journal-title":"Nephrology"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Sam, Q.H., Ling, H., Yew, W.S., Tan, Z., Ravikumar, S., Chang, M.W., and Chai, L.Y.A. (2021). The Divergent Immunomodulatory Effects of Short Chain Fatty Acids and Medium Chain Fatty Acids. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126453"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Hu, M., Alashkar Alhamwe, B., Santner-Nanan, B., Miethe, S., Harb, H., Renz, H., Potaczek, D.P., and Nanan, R.K. (2022). Short-Chain Fatty Acids Augment Differentiation and Function of Human Induced Regulatory T Cells. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105740"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/qjmed\/hct205","article-title":"Prognostic Impact of Systemic Inflammatory Diseases in Elderly Patients with Congestive Heart Failure","volume":"107","author":"Burkard","year":"2013","journal-title":"QJM"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.arcmed.2019.12.020","article-title":"Indoxyl Sulfate Contributes to Uremic Sarcopenia by Inducing Apoptosis in Myoblasts","volume":"51","author":"Rodrigues","year":"2020","journal-title":"Arch. Med. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: Revised European Consensus on Definition and Diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0261-5614(03)00048-7","article-title":"Validation of a Bioelectrical Impedance Analysis Equation to Predict Appendicular Skeletal Muscle Mass (ASMM)","volume":"22","author":"Kyle","year":"2003","journal-title":"Clin. Nutr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 301 Acute and Chronic Diseases and Injuries in 188 Countries, 19902013: A Systematic Analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Vos","year":"2015","journal-title":"Lancet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random Forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/1\/550\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:07:16Z","timestamp":1767629236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/1\/550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["ijms27010550"],"URL":"https:\/\/doi.org\/10.3390\/ijms27010550","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]}}}